Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2010
08/25/2010CN1882319B Anti-tumour terpene compounds
08/25/2010CN1872112B Drop pills of total saponin of gen-seng haulms, and preparation method
08/25/2010CN1830486B Application of pumpkin protein in preparation of medicine
08/25/2010CN1780627B Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis
08/25/2010CN1771984B New use of extracellular polysaccharide of halophilous aphanothece
08/25/2010CN101815725A anti cd37 antibodies
08/25/2010CN101815724A aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
08/25/2010CN101815714A Thiazol derivatives
08/25/2010CN101815712A Pyrazole compounds and their use as RAF inhibitors
08/25/2010CN101815710A Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
08/25/2010CN101812491A Method for producing pleurotus ferulae polysaccharide and oral liquid thereof through fermentation
08/25/2010CN101812477A Construction of targeted anti-tumor oncolytic adenovirus carrier for expressing superantigen SEA (staphylococcus aureus enterotoxin A) gene
08/25/2010CN101812456A Ribonucleic acid taking liver cancer related gene DLK1 as target spot and application thereof
08/25/2010CN101812455A Ribonucleic acid taking liver cancer related gene DLK1 as target spot and application thereof
08/25/2010CN101812454A Ribonucleic acid taking liver cancer related gene DLK1 as target spot and application thereof
08/25/2010CN101812453A Ribonucleic acid taking liver cancer related gene DLK1 as target spot and application thereof
08/25/2010CN101812452A Application of small interfering RNA (Ribonucleic Acid) of RALA (v-ral simian leukemia viral oncogene homolog A) gene in preparing medicaments for resisting leukemia
08/25/2010CN101812448A Sequence for expressing targeted double-recombinant apoptosis proteins of liver cancer and application thereof
08/25/2010CN101812438A Arginine deiminase mutant and preparation and application thereof
08/25/2010CN101812292A Method for preparing protein ribonuclease modified zinc telluride quantum dot
08/25/2010CN101812190A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101812189A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101812134A Antibodies that bind cell-associated ca 125/0722p and methods of use thereof
08/25/2010CN101812133A Receptor, the use thereof, and mouse antibodies
08/25/2010CN101812127A Microtubule-associated protein and coding genes and application thereof
08/25/2010CN101812126A Novel HLA-A2 restrictive epitope polypeptide coming from hPEBP4 protein and application thereof
08/25/2010CN101812118A Specific binding agents of human angiopoietin-2
08/25/2010CN101812105A Cytarabine 5'-O-amino-acid ester, salts thereof and preparation method thereof
08/25/2010CN101812103A 6-methy salicylic acid synthetase transformed by genetic engineering and combinatorial biosynthesis of spirocyclic acetoacetic acid lactone antiboitic
08/25/2010CN101812097A Indole carbazole and bisindole maleimide alkaloid, preparation method and application thereof
08/25/2010CN101812092A Manganese compound and preparation method and application thereof
08/25/2010CN101812079A Piprazine compound containing polysulfide bond and preparation method and application thereof
08/25/2010CN101812066A Pyrazolo N-substituted dehydronorcantharidin imide derivative as well as synthesis method, activity test method and application thereof
08/25/2010CN101812063A Alpha-naphthalenesulfonamide base quintuple heterocyclic compound and anti-tumor activity thereof
08/25/2010CN101812059A Nitric oxide donor-type farnesyl thiosalicylic acid derivative, and preparation method and medical application thereof
08/25/2010CN101812040A Corossolone derivative, preparation method and application thereof
08/25/2010CN101812008A IDO inhibitor containing pyrrole-2-aryl structure and preparation method thereof
08/25/2010CN101812007A Aminopyrrole compound and preparation method thereof
08/25/2010CN101810865A Bi-target treatment for bladder cancer by non-fusion Adeno-associated virus carrier of tumstatin Tumstatin and suicide gene HSV-TK
08/25/2010CN101810862A Tanshinone IIA oral administration polymer micelle composition
08/25/2010CN101810860A Medicinal composition having tumor-resistant synergy
08/25/2010CN101810858A Microcrystalline glass microspheres with magnetism and radioactivity, preparation method and application thereof
08/25/2010CN101810857A New application of anti-phosphatidylserine receptor antibody on treating cancer
08/25/2010CN101810841A Formula of orally-taken Chinese medicament for treating hemangioma
08/25/2010CN101810827A Chinese medicinal preparation for treating mammary aggregation
08/25/2010CN101810826A Chinese medicament for treating liver cancer
08/25/2010CN101810710A Method for extracting total anthraquinone in medicinal indianmulberry root
08/25/2010CN101810696A Total triterpenoids of apples and method for preparing same
08/25/2010CN101810667A Medicine composition for auxiliary treatment of cancer
08/25/2010CN101810662A Elephantopus scaber linn extractive, preparation method and applications thereof
08/25/2010CN101810659A Total saponins of salvia chinensis benth, and medical application and preparation method thereof
08/25/2010CN101810651A Preparation method of kiwifruit frozen and dried fruit vegetable product with function of tumor inhibition
08/25/2010CN101810637A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101810634A Application of tunicamycin in preparing medicament for inhibiting migration of prostate cancer cells
08/25/2010CN101810624A Medicament for treating colon cancer and preparation method thereof
08/25/2010CN101810620A Methionine-vitamin B1 composite injection and preparation method thereof
08/25/2010CN101810608A Anti-tumor small molecule compound targeting at human phosphatidylethanolamine-bindingprotein-4
08/25/2010CN101810593A Elemene sustained-release tablets
08/25/2010CN101810591A Mangiferin dispersible tablets and preparation method thereof
08/25/2010CN101810587A Preparation technology for microspheric embolization agent
08/25/2010CN101810579A Oral spray or aerosol containing Palonosetron
08/25/2010CN101810577A Gossypol intravenous injection fatty emulsion for curing tumors
08/25/2010CN101810574A Method for preparing stable docetaxel submicron emulsion injection and freeze-dried emulsion
08/25/2010CN101810570A Lipid nano particle preparation containing composite formed fatty acid and anthracyclines antitumor antibiotics and preparation method thereof
08/25/2010CN101361714B Vincristine-reversal agent composite nano-granule and preparation method and use thereof
08/25/2010CN101361713B Curcumin nano crystallization preparation and preparation method thereof
08/25/2010CN101322737B Persimmon leaf flavones extract and preparation thereof
08/25/2010CN101322700B Applications of naringenin and naringin as signal pathway inhibitor of transforming growth factor-beta 1
08/25/2010CN101289440B Polyene macrocyclic compounds, preparation thereof and applications
08/25/2010CN101264311B Natural pharmaceutical composition, its preparation and its attenuation synergistic use in cancer radiotherapy and chemotherapy
08/25/2010CN101157652B Antitumor activity bipyridine methyl amine compound and preparation method thereof
08/25/2010CN101143170B Traditional Chinese medicine composition for treating rectum cancer
08/25/2010CN101138558B Pentamidine and death domain receptor ligand united application
08/25/2010CN101108252B Pharmaceutical composition of cyclodextrin dragon's blood and method of preparing the same
08/25/2010CN101092420B (1Z, 4Z, 5Z) - 6 N isopropyl - 6 - aza -2 - oxo - 3 - oxa - 4 - methoxy - dicyclo [3, 1, 0] hexane and preparation method
08/25/2010CN101066261B Application of dryopteris fragrans phloroglucinol extract
08/25/2010CN101028305B Ganoderic spore extract and its production
08/24/2010US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/24/2010US7781587 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one
08/24/2010US7781584 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
08/24/2010US7781583 Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d] pryimidin-7-ones
08/24/2010US7781566 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
08/24/2010US7781463 Enzyme inhibitors
08/24/2010US7781458 Derivatives of pyridine and quinoline
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010US7781450 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer
08/24/2010US7781447 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
08/24/2010US7781446 renal cancer; after standard chemotherapy; rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779)
08/24/2010US7781440 Neurodegenerative diseases caused by GSK3 such as Alzheimer's disease
08/24/2010US7781398 Drug comprising synthetic peptide analogs for the treatment of cancer
08/24/2010US7781397 Immunoaffinity purification
08/24/2010US7781188 Nucleotide and protein sequences of Nogo genes and methods based thereon
08/24/2010US7781161 Detection cancer; controlling gene expression; detection hybrids
08/24/2010US7780983 Amphoteric liposomes
08/24/2010US7780953 Based on iron oxide, complexed by gem-bisphosphonate compounds, coupled to biovector (protein); colloids; peptization; for use as contrast agents for magnetic resonance imaging; labelling stem cells
08/24/2010CA2520897C Pyrrolo (2,1-c)(1,4) benzodiazepine dimers as antitumour agents and process thereof
08/24/2010CA2511219C Cyclopentenone derivatives for cancer therapy
08/24/2010CA2490907C Amide derivative
08/24/2010CA2460135C Use of pyridazinone compounds as phosphodiesterase iv inhibitors for treating cancer and other diseases
08/24/2010CA2445940C Prevention of epithelial cancer
1 ... 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 ... 2211